Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Treatment Modalities for Graves' Ophthalmopathy - Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 06/15/09
Stiebel-Kalish H et al. - Current evidence demonstrates the efficacy of intravenous corticosteroids in decreasing CAS in patients with moderate-to-severe GO. Intravenous pulse corticosteroids therapy has a small but statistically significant advantage oral therapy, and causes significantly less adverse events. Somatostatin analogs have marginal clinical efficacy. The efficacy of orbital radiotherapy as single therapy remains unclear, while the combination of radiotherapy with corticosteroids has better efficacy than either radiotherapy or oral costicosteroids alone.
Related Articles
Co-existence of Euthyroid Graves Ophthalmopathy and Isolated Ocular Myasthenia in a Patient with Vitiligo: A Challenging Diagnosis of Auto-immune Polyglandular Syndrome-3C
Neuro-Ophthalmology, 10/15/09
Relevance Score: 66%
Recession of the inferior rectus muscle in Graves' orbitopathy
Eye, 11/18/09
Relevance Score: 65%
Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' Ophthalmopathy
Investigative Ophthalmology and Visual Science, 10/15/09
Relevance Score: 65%
Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes
Eye, 10/07/09
Relevance Score: 64%
Recurrence of Graves' Disease in Thyroglossal Duct Remnants: Relapse After Total Thyroidectomy
Thyroid, 11/19/09
Relevance Score: 44%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Today in Thyroid/Parathyroid...keeping you current
Receive free subspecialty "5-minute updates" via email
Controversies in Thyroid Pathology: Thyroid Capsule Invasion and Extrathyroidal Extension
Annals of Surgical Oncology, 12/08/09
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
European Journal of Nuclear Medicine & Molecular Imaging, 12/08/09
Parathyroidectomy in the elderly population: Does age really matter
The Laryngoscope, 12/08/09
Sponsor
Article Search
Sponsor


See Latest Articles


